February 2011 Vol. 6 No. 2

elder nurse old age

Can a nurse be too old to work at the bedside?

Read guest blogger Donna Cardillo’s thought-provoking article about when age comes into play during a nurse’s career. A recent New York Times article begged the question, “How old…

Common sense about cold sores

You have been looking forward to your nursing class reunion for months. The day finally arrives; but to your horror, a large cold sore has appeared! It’s ugly…

FDA approves drug to reduce risk of preterm birth

The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with a history of at…

FDA approves new drug for COPD

The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm244989.htm

FDA approves new drug for lupus

The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm246489.htm.

FDA warning for terbutaline in preterm labor

The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women for prevention or prolonged…

Fidaxomicin reduces C. diff recurrence

Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.

NEJM: Perspective on foodborne diseases

The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.

The genetics of colorectal cancer

A 52-year-old patient arrives at the busy family practice office where you work for his follow-up visit. He had not undergone colon cancer screening, despite his age, but…

Common sense about cold sores

You have been looking forward to your nursing class reunion for months. The day finally arrives; but to your horror, a large cold sore…

FDA approves new drug for COPD

The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…

FDA approves new drug for lupus

The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955.…

Fidaxomicin reduces C. diff recurrence

Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.

NEJM: Perspective on foodborne diseases

The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.

The genetics of colorectal cancer

A 52-year-old patient arrives at the busy family practice office where you work for his follow-up visit. He had not undergone colon cancer screening,…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Poll

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.